315 related articles for article (PubMed ID: 33973802)
1. How has nanomedical innovation contributed to the COVID-19 vaccine development?
Figueiró Longo JP; Muehlmann LA
Nanomedicine (Lond); 2021 Jun; 16(14):1179-1181. PubMed ID: 33973802
[No Abstract] [Full Text] [Related]
2. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
Milane L; Amiji M
Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
[TBL] [Abstract][Full Text] [Related]
3. Special Focus Issue - Applications of nanotechnology against COVID-19: a special focus issue by
Bough A
Nanomedicine (Lond); 2021 Jun; 16(14):1177-1178. PubMed ID: 34044606
[No Abstract] [Full Text] [Related]
4. COVID-19 may become nanomedicine's finest hour yet.
Friedrichs S; Bowman DM
Nat Nanotechnol; 2021 Apr; 16(4):362-364. PubMed ID: 33854220
[No Abstract] [Full Text] [Related]
5. Issues affecting nanomedicines on the way from the bench to the market.
Longo JPF; Mussi S; Azevedo RB; Muehlmann LA
J Mater Chem B; 2020 Dec; 8(47):10681-10685. PubMed ID: 33155000
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine and the COVID-19 vaccines.
Nat Nanotechnol; 2020 Dec; 15(12):963. PubMed ID: 33247210
[TBL] [Abstract][Full Text] [Related]
7. Nanomedical engineering: shaping future nanomedicines.
Luo D; Carter KA; Lovell JF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
[TBL] [Abstract][Full Text] [Related]
8. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
[TBL] [Abstract][Full Text] [Related]
9. A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa.
Dube A; Egieyeh S; Balogun M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696526
[TBL] [Abstract][Full Text] [Related]
10. Biotechnology, nanotechnology and medicine.
Contera S; Bernardino de la Serna J; Tetley TD
Emerg Top Life Sci; 2020 Dec; 4(6):551-554. PubMed ID: 33295610
[TBL] [Abstract][Full Text] [Related]
11. Latest developments in innovative manufacturing to combine nanotechnology with healthcare.
Parhizkar M; Mahalingam S; Homer-Vanniasinkam S; Edirisinghe M
Nanomedicine (Lond); 2018 Jan; 13(1):5-8. PubMed ID: 29185387
[No Abstract] [Full Text] [Related]
12. COVID-19 vaccine development and a potential nanomaterial path forward.
Shin MD; Shukla S; Chung YH; Beiss V; Chan SK; Ortega-Rivera OA; Wirth DM; Chen A; Sack M; Pokorski JK; Steinmetz NF
Nat Nanotechnol; 2020 Aug; 15(8):646-655. PubMed ID: 32669664
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology: 21st century revolution in restorative healthcare.
Venugopal JR; Ramakrishna S
Nanomedicine (Lond); 2016 Jun; 11(12):1511-3. PubMed ID: 27199155
[No Abstract] [Full Text] [Related]
15. Nanotechnology versus coronavirus.
Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
[No Abstract] [Full Text] [Related]
16. Nanomedicine and nanotechnology are rapidly developing fields across the nation and worldwide.
Alakhova DY; Kabanov AV
J Control Release; 2015 Jun; 208():1. PubMed ID: 25965907
[No Abstract] [Full Text] [Related]
17. The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine.
Vulpis E; Giulimondi F; Digiacomo L; Zingoni A; Safavi-Sohi R; Sharifi S; Caracciolo G; Mahmoudi M
Mol Pharm; 2021 Jun; 18(6):2448-2453. PubMed ID: 33983745
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology and cancer nanomedicine.
Liang XJ
Biotechnol Adv; 2014; 32(4):665. PubMed ID: 24913056
[No Abstract] [Full Text] [Related]
19. Nanomedicine for the poor: a lost cause or an idea whose time has yet to come?
Uskoković V
Nanomedicine (Lond); 2021 Jun; 16(14):1203-1218. PubMed ID: 33988035
[TBL] [Abstract][Full Text] [Related]
20. [Nanotechnologies and nanomedicine].
Rusu V
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):217-9. PubMed ID: 16607773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
